Overview

Over Active Bladder Patients Having Sling Surgery

Status:
Completed

Trial end date:
2010-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether treatment with anti-muscarinic medications following sub-urethral sling procedures improves overall subjective and objective outcomes in women with mixed incontinence with primary stress symptoms.

Phase:

Phase 4

Details

Lead Sponsor:

Cleveland Clinic Florida

Collaborator:

Astellas Pharma US, Inc.

Treatments:

Solifenacin Succinate
Tolterodine Tartrate